Sulfuric Acid

Sulfuric Acid

SCHEMBL519200

Cc1ccc2c(c1)nc1ccc(Nc3ccccc3)cc1[n+]2-c1ccccc1.Cc1ccc2c(c1)nc1ccc(Nc3ccccc3)cc1[n+]2-c1ccccc1.O=S(=O)([O-])[O-]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
GNG2 P59768 1/20 0.42
GNB1 P62873 1/20 0.42
ENPP2 Q13822 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
NPSR1 Q6W5P4 1/20 0.38
BRD4 O60885 1/20 0.38
SNCA P37840 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9278848 0.93 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6GNG2GNB1
SCHEMBL10005148 0.87 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP2D6GNG2GNB1
SCHEMBL11954428 0.83 HPGD (0.49) ALDH1A1CYP1A2CYP2D6GNG2GNB1
SCHEMBL10005072 0.82 ALDH1A1 (0.55) ALDH1A1CYP1A2CYP2D6GNG2GNB1
Sulfuric Acid SCHEMBL866069 0.81 ENPP2 (0.42) ALDH1A1CYP1A2CYP2D6GNG2GNB1
Sulfuric Acid SCHEMBL519239 0.81 L3MBTL1 (0.46) ALDH1A1L3MBTL1MEN1KMT2AGAA
SCHEMBL11954455 0.79 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2D6GNG2GNB1
Sulfuric Acid SCHEMBL518534 0.78 NPC1 (0.37) ALDH1A1ENPP2L3MBTL1MEN1KMT2A
SCHEMBL10005108 0.78 MEN1 (0.51) ALDH1A1CYP1A2CYP2D6GNG2GNB1
SCHEMBL20969309 0.78 L3MBTL1 (0.55) ALDH1A1CYP1A2CYP2D6GNG2GNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0598763-B1 ACID BATH FOR THE GALVANIC DEPOSITION OF COPPER, AND THE USE OF SUCH A BATH ATOTECH DEUTSCHLAND GMBH (DE) 1995-12-13 EP claimed
EP-4018791-A1 METHOD OF PREPARING A HIGH DENSITY INTERCONNECT PRINTED CIRCUIT BOARD INCLUDING MICROVIAS FILLED WITH COPPER Atotech Deutschland GmbH & Co. KG (DE) 2022-06-29 EP disclosed
EP-4018790-A1 MANUFACTURING SEQUENCES FOR HIGH DENSITY INTERCONNECT PRINTED CIRCUIT BOARDS AND A HIGH DENSITY INTERCONNECT PRINTED CIRCUIT BOARD Atotech Deutschland GmbH & Co. KG (DE) 2022-06-29 EP disclosed
US-10982343-B2 Plating compositions for electrolytic copper deposition, its use and a method for electrolytically depositing a copper or copper alloy layer onto at least one surface of a substrate ATOTECH DEUTSCHLAND GMBH (DE) 2021-04-20 US disclosed
US-20200347504-A1 PLATING COMPOSITIONS FOR ELECTROLYTIC COPPER DEPOSITION, ITS USE AND A METHOD FOR ELECTROLYTICALLY DEPOSITING A COPPER OR COPPER ALLOY LAYER ONTO AT LEAST ONE SURFACE OF A SUBSTRATE ATOTECH DEUTSCHLAND GMBH (DE) 2020-11-05 US disclosed
EP-3483307-B1 PLATING COMPOSITIONS FOR ELECTROLYTIC COPPER DEPOSITION, ITS USE AND A METHOD FOR ELECTROLYTICALLY DEPOSITING A COPPER OR COPPER ALLOY LAYER ONTO AT LEAST ONE SURFACE OF A SUBSTRATE ATOTECH DEUTSCHLAND GMBH (DE) 2020-04-01 EP disclosed
EP-3483307-A1 PLATING COMPOSITIONS FOR ELECTROLYTIC COPPER DEPOSITION, ITS USE AND A METHOD FOR ELECTROLYTICALLY DEPOSITING A COPPER OR COPPER ALLOY LAYER ONTO AT LEAST ONE SURFACE OF A SUBSTRATE ATOTECH Deutschland GmbH (DE) 2019-05-15 EP disclosed
EP-2619244-B1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN INC (US) 2018-11-14 EP disclosed
US-9040700-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2015-05-26 US disclosed
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds MACDERMID ACUMEN, INC. (US) 2014-06-12 US disclosed
US-8735580-B2 Method of producing polymeric phenazonium compounds CITIBANK, N.A. 2014-05-27 US disclosed
CN-102318041-B PROCESS FOR ELECTRODEPOSITION OF COPPER CHIP TO CHIP, CHIP TO WAFER AND WAFER TO WAFER INTERCONNECTS IN THROUGH-SILICON VIAS (TSV) ATOTECH DEUTSCHLAND GMBH 2014-05-07 CN disclosed
EP-2619244-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MacDermid Acumen, Inc. (US) 2013-07-31 EP disclosed
CN-103038397-A Method for electrodepositing chip-to-chip, chip-to-wafer, and wafer-to-wafer copper interconnects in Through Silicon Vias (TSVs) by heating the substrate and cooling the electrolyte ATOTECH DEUTSCHLAND GMBH 2013-04-10 CN disclosed
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US disclosed
US-20120077956-A1 Method of Producing Polymeric Phenazonium Compounds CITIBANK, N.A. 2012-03-29 US disclosed
WO-2012040417-A1 IMPROVED METHOD OF PRODUCING POLYMERIC PHENAZONIUM COMPOUNDS MACDERMID ACUMEN, INC. (US) 2012-03-29 WO disclosed
US-20120024713-A1 PROCESS FOR ELECTRODEPOSITION OF COPPER CHIP TO CHIP, CHIP TO WAFER AND WAFER TO WAFER INTERCONNECTS IN THROUGH-SILICON VIAS (TSV) WITH HEATED SUBSTRATE AND COOLED ELECTROLYTE ATOTECH DEUTSCHLAND GMBH (DE) 2012-02-02 US disclosed
CN-102318041-A PROCESS FOR ELECTRODEPOSITION OF COPPER CHIP TO CHIP, CHIP TO WAFER AND WAFER TO WAFER INTERCONNECTS IN THROUGH-SILICON VIAS (TSV) ATOTECH DEUTSCHLAND GMBH 2012-01-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120073981-A1 Method of Producing Polymeric Phenazonium Compounds NOX5, PRMT5, CHRM5 ALDH1A1 2815/4885CYP1A2 1412/4885CYP2D6 1225/4885
US-20140163198-A1 Method of Producing Polymeric Phenazonium Compounds NOX5, PRMT5, H1-5 ALDH1A1 2671/4885CYP1A2 1668/4885CYP2D6 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.